BioSpace News Archive

Business

Inspire Medical Systems, Inc. to Report Second Quarter 2023 Financial Results on August 1, 2023

Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the second quarter 2023 after the close of trading on Tuesday, August 1.

July 5, 2023
·
1 min read
Drug Development

Positive Aggregate Safety Data From Vafidemstat’s Ongoing Phase IIb PORTICO Trial in Borderline Personality Disorder

Oryzon Genomics, S.A. today reports new preliminary blinded aggregate safety data from its ongoing Phase IIb PORTICO trial, investigating vafidemstat in Borderline Personality Disorder (BPD).

July 5, 2023
·
7 min read
BioCapital

I-Mab Announces Publication of Claudin18.2 x 4-1BB Bispecific Antibody Givastomig in JITC

I-Mab today announced the publication of a manuscript entitled “CLDN18.2 and 4-1BB bispecific antibody givastomig exerts antitumor activity through CLDN18.2-expressing tumor-directed T-cell activation” in the latest issue of The Journal for Immuno-Therapy of Cancer (JITC).

July 5, 2023
·
6 min read
Business

EDIRNA, Inc. announces establishment of Executive Team and Strategic Partnership with a Global RNA Biopharmaceutical Company

EDIRNA, Inc. (the " Company " or " EDIRNA "), an innovative biotechnology company focused on RNA-Editing therapeutics, announces establishment of executive management team led by experienced biopharma executive, Christopher W. Kennedy , as the Company’s President and Chief Executive Officer.

July 5, 2023
·
3 min read
Business

Coya Therapeutics (“Coya”) Appoints Industry and Drug Development Veteran, Dr. Fred Grossman, to President and Chief Medical Officer succeeding Dr. Adrian Hepner

Coya Therapeutics, Inc. (NASDAQ: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company developing biologics intended to enhance Treg function, today announced the appointment of Dr. Fred Grossman to its senior management team as President and Chief Medical Officer.

July 5, 2023
·
7 min read
Lone Star Bio

CNS Pharmaceuticals to Participate in the Virtual Investor Summer Spotlight Series

CNS Pharmaceuticals, Inc. today announced that John Climaco, Chief Executive Officer and Sandra L. Silberman, M.D., Ph.D., Chief Medical Officer of CNS Pharmaceuticals will participate in the Virtual Investor Summer Spotlight Series on Tuesday, July 11, 2023 at 12:00 PM ET.

July 5, 2023
·
1 min read
FDA

Abbott Receives FDA Approval for World’s First Dual-Chamber Leadless Pacemaker

Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved the AVEIR™ dual chamber (DR) leadless pacemaker system, the world’s first dual chamber leadless pacing system that treats people with abnormal or slow heart rhythms.

July 5, 2023
·
5 min read
Business

Altamira Therapeutics Announces Collaboration with Heqet Therapeutics on Nanoparticle-Delivered Non-Coding RNAs for Cardiac Regeneration

Heqet will test nanoparticles based on Altamira’s OligoPhore delivery platform in the regeneration of damaged heart tissue Altamira Therapeutics Ltd. today announced that it has entered into a collaboration and option agreement with Heqet Therapeutics s.r.l.

July 5, 2023
·
7 min read
Drug Development

Sorrento Announces Positive Phase IIa Study Results of Abivertinib for the Treatment of Relapsed/Refractory Marginal Zone Lymphoma (R/R MZL) and Its Plan for a Pivotal Phase III Study

Sorrento Therapeutics, Inc. (OTC: SRNEQ) today announced positive results from a China phase IIa study of Abivertinib on R/R MZL and its plan for a pivotal study.

July 5, 2023
·
8 min read
Business

PENTAX MEDICAL ANNOUNCES THE APPOINTMENT OF DAVID HARRISON AS THE NEW PRESIDENT FOR THE AMERICAS

PENTAX Medical, a healthcare industry leader in diagnostic and therapeutic endoscopy, is pleased to announce the appointment of David Harrison as President of the Americas.

July 5, 2023
·
3 min read